Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1995 2
1996 1
1998 1
2002 1
2008 1
2014 1
2018 1
2019 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Myxoid liposarcoma of the ankle.
Werd MB, DeFronzo DJ, Landsman AS, Surprenant M, Sakoff M. Werd MB, et al. Among authors: surprenant m. J Foot Ankle Surg. 1995 Sep-Oct;34(5):465-74. doi: 10.1016/S1067-2516(09)80022-7. J Foot Ankle Surg. 1995. PMID: 8590881 Review.
Man With Bilateral Heel Pain.
Zarnett O, Umran T, Surprenant M, Lahiffe B, Scheuermeyer FX. Zarnett O, et al. Among authors: surprenant m. Ann Emerg Med. 2019 May;73(5):542-544. doi: 10.1016/j.annemergmed.2018.11.038. Ann Emerg Med. 2019. PMID: 31029289 No abstract available.
Implantable bone substitute materials.
Hanft JR, Sprinkle RW, Surprenant MS, Werd MB. Hanft JR, et al. Among authors: surprenant ms. Clin Podiatr Med Surg. 1995 Jul;12(3):437-55. Clin Podiatr Med Surg. 1995. PMID: 7553534 Review.
Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
Gupta AK, Surprenant MS, Kempers SE, Pariser DM, Rensfeldt K, Tavakkol A. Gupta AK, et al. Among authors: surprenant ms. J Am Acad Dermatol. 2021 Jul;85(1):95-104. doi: 10.1016/j.jaad.2020.06.055. Epub 2020 Jun 22. J Am Acad Dermatol. 2021. PMID: 32585278 Clinical Trial.
Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study.
Vinik A, Rosenstock J, Sharma U, Feins K, Hsu C, Merante D; DS5565-A-U201 US Phase II Study Investigators. Vinik A, et al. Diabetes Care. 2014 Dec;37(12):3253-61. doi: 10.2337/dc14-1044. Epub 2014 Sep 17. Diabetes Care. 2014. PMID: 25231896 Clinical Trial.
11 results